The Gut Microbiome and Treatment-Resistance in Schizophrenia

@article{Seeman2019TheGM,
  title={The Gut Microbiome and Treatment-Resistance in Schizophrenia},
  author={M. Seeman},
  journal={Psychiatric Quarterly},
  year={2019},
  volume={91},
  pages={127-136}
}
  • M. Seeman
  • Published 2019
  • Medicine, Psychology
  • Psychiatric Quarterly
  • The effect of antipsychotic medication is poor in 30–40% of patients with schizophrenia; treatment resistance is usually met with shifts to new drugs or drug augmentation strategies or a trial of clozapine. The purpose of this review was to examine the potential role of intestinal bacteria in the bioavailability of antipsychotic medication and the possibility that parenterally administered antipsychotics might be able to overcome treatment resistance. Databases were searched with appropriate… CONTINUE READING

    Paper Mentions

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 88 REFERENCES
    Drug–gut microbiota interactions: implications for neuropharmacology
    19
    Extensive impact of non-antibiotic drugs on human gut bacteria
    467
    Intranasal delivery of antipsychotic drugs
    16